- Home
- RNAC vs UNTY Comparison
RNAC vs UNTY Comparison
Compare RNAC & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- UNTY
- Stock Information
- Founded
- RNAC 2007
- UNTY 1991
- Country
- RNAC United States
- UNTY United States
- Employees
- RNAC N/A
- UNTY N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- UNTY Major Banks
- Sector
- RNAC Health Care
- UNTY Finance
- Exchange
- RNAC Nasdaq
- UNTY Nasdaq
- Market Cap
- RNAC 291.7M
- UNTY N/A
- IPO Year
- RNAC 2016
- UNTY 1997
- Fundamental
- Price
- RNAC $10.42
- UNTY $44.02
- Analyst Decision
- RNAC Strong Buy
- UNTY Buy
- Analyst Count
- RNAC 7
- UNTY 2
- Target Price
- RNAC $41.00
- UNTY $52.50
- AVG Volume (30 Days)
- RNAC 86.8K
- UNTY 33.2K
- Earning Date
- RNAC 05-08-2025
- UNTY 04-11-2025
- Dividend Yield
- RNAC N/A
- UNTY 1.26%
- EPS Growth
- RNAC N/A
- UNTY 11.85
- EPS
- RNAC N/A
- UNTY 4.26
- Revenue
- RNAC $34,173,000.00
- UNTY $106,250,000.00
- Revenue This Year
- RNAC N/A
- UNTY $21.68
- Revenue Next Year
- RNAC N/A
- UNTY $9.98
- P/E Ratio
- RNAC N/A
- UNTY $10.44
- Revenue Growth
- RNAC 31.91
- UNTY 6.60
- 52 Week Low
- RNAC $8.85
- UNTY $25.60
- 52 Week High
- RNAC $41.87
- UNTY $51.22
- Technical
- Relative Strength Index (RSI)
- RNAC 39.42
- UNTY 61.37
- Support Level
- RNAC $11.18
- UNTY $42.40
- Resistance Level
- RNAC $13.10
- UNTY $43.73
- Average True Range (ATR)
- RNAC 0.90
- UNTY 1.38
- MACD
- RNAC 0.04
- UNTY 0.34
- Stochastic Oscillator
- RNAC 24.61
- UNTY 76.67
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.